A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis | Zendy

Corinne Merle | Zendy; Katherine Fielding | Zendy; Omou Bah Sow | Zendy; M. Gninafon | Zendy; Mame Bocar Lo | Zendy; Thuli Mthiyane | Zendy; Joseph Odhiambo | Zendy; Evans Amukoye | Zendy; Boubacar Bah | Zendy; Ferdinand Kassa | Zendy; Alimatou N′Diaye | Zendy; Roxana Rustomjee | Zendy; Bouke C. de Jong | Zendy; John Horton | Zendy; Christian Perronne | Zendy; Charalambos Sismanidis | Zendy; Olivier Lapujade | Zendy; Piero Olliaro | Zendy; Christian Lienhardt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis

Author(s) -

Corinne Merle,

Katherine Fielding,

Omou Bah Sow,

M. Gninafon,

Mame Bocar Lo,

Thuli Mthiyane,

Joseph Odhiambo,

Evans Amukoye,

Boubacar Bah,

Ferdinand Kassa,

Alimatou N′Diaye,

Roxana Rustomjee,

Bouke C. de Jong,

John Horton,

Christian Perronne,

Charalambos Sismanidis,

Olivier Lapujade,

Piero Olliaro,

Christian Lienhardt

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1315817

Subject(s) - gatifloxacin , medicine , regimen , tuberculosis , pathogenic organism , antibiotics , pathology , microbiology and biotechnology , biology , ciprofloxacin

Shortening the course of treatment for tuberculosis would be a major improvement for case management and disease control. This phase 3 trial assessed the efficacy and safety of a 4-month gatifloxacin-containing regimen for treating rifampin-sensitive pulmonary tuberculosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research